Patents by Inventor Olga BOICO
Olga BOICO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240029818Abstract: A method of analyzing biological data containing expression values of a plurality of polypeptides in the blood of a subject. The method comprises: calculating a distance between a segment of a curved line and an axis defined by a direction, the distance being calculated at a point over the curved line defined by a coordinate along the direction. The method further comprises correlating the distance to the presence of, absence of, or likelihood that the subject has, a bacterial infection. The coordinate is defined by a combination of the expression values, wherein at least 90% of the segment is between a lower bound line and an upper bound line.Type: ApplicationFiled: August 7, 2023Publication date: January 25, 2024Applicant: MeMed Diagnostics Ltd.Inventors: Eran EDEN, Kfir OVED, Roy NAVON, Assaf COHEN-DOTAN, Olga BOICO
-
Patent number: 11776658Abstract: A method of analyzing biological data containing expression values of a plurality of polypeptides in the blood of a subject. The method comprises: calculating a distance between a segment of a curved line and an axis defined by a direction, the distance being calculated at a point over the curved line defined by a coordinate along the direction. The method further comprises correlating the distance to the presence of, absence of, or likelihood that the subject has, a bacterial infection. The coordinate is defined by a combination of the expression values, wherein at least 90% of the segment is between a lower bound line and an upper bound line.Type: GrantFiled: July 28, 2022Date of Patent: October 3, 2023Assignee: MeMed Diagnostics Ltd.Inventors: Eran Eden, Kfir Oved, Roy Navon, Assaf Cohen-Dotan, Olga Boico
-
Publication number: 20230184760Abstract: A method of determining an infection type in a subject is disclosed. The method comprises measuring the concentration of a first determinant selected from the group consisting of the determinants which are set forth in Table 1 and a second determinant selected from the group of the determinants which are set forth in Table 2 in a subject derived sample, wherein the concentration is indicative of the infection type.Type: ApplicationFiled: December 8, 2022Publication date: June 15, 2023Applicant: MeMed Diagnostics Ltd.Inventors: Kfir OVED, Eran EDEN, Gali KRONENFELD, Olga BOICO, Roy NAVON, Assaf COHEN-DOTAN
-
Publication number: 20230094142Abstract: A method of classifying the severity of a coronaviral infection of a subject is disclosed. The method comprises measuring the TRAIL and/or IP10 protein level in a body liquid sample of the subject, wherein the level is indicative of the severity of the coronaviral infection. Managing treatments for coronaviral infections are also disclosed as well as measuring contagiousness of infections.Type: ApplicationFiled: January 29, 2021Publication date: March 30, 2023Applicant: MeMed Diagnostics Ltd.Inventors: Niv Steven MASTBOIM, Oded SHAHAM, Roy NAVON, Tahel ILAN BER, Shaul LEV, Eran BARASH, Tanya Michelle GOTTLIEB, Meital PAZ, Olga BOICO, Kfir OVED, Eran EDEN
-
Publication number: 20230045305Abstract: Methods of determining infection type are disclosed. In one embodiment, the method comprises measuring the amount of a determinant which is set forth in Tables 1 or 2 in a sample derived from the subject, wherein said amount is indicative of the infection type.Type: ApplicationFiled: September 29, 2022Publication date: February 9, 2023Applicant: MeMed Diagnostics Ltd.Inventors: Kfir OVED, Eran EDEN, Olga BOICO, Gali KRONENFELD, Roy NAVON, Assaf COHEN-DOTAN, Einav SIMON
-
Publication number: 20220399074Abstract: A method of analyzing biological data containing expression values of a plurality of polypeptides in the blood of a subject. The method comprises: calculating a distance between a segment of a curved line and an axis defined by a direction, the distance being calculated at a point over the curved line defined by a coordinate along the direction. The method further comprises correlating the distance to the presence of, absence of, or likelihood that the subject has, a bacterial infection. The coordinate is defined by a combination of the expression values, wherein at least 90% of the segment is between a lower bound line and an upper bound line.Type: ApplicationFiled: July 28, 2022Publication date: December 15, 2022Applicant: MeMed Diagnostics Ltd.Inventors: Eran EDEN, Kfir OVED, Roy NAVON, Assaf COHEN-DOTAN, Olga BOICO
-
Publication number: 20220326256Abstract: A method of determining a management course for treating a subject showing symptoms of a disease is disclosed. The method comprises measuring the TRAIL protein level in a blood sample of the subject, wherein when the TRAIL level is below a predetermined amount, the subject is treated as a high-risk patient.Type: ApplicationFiled: June 16, 2022Publication date: October 13, 2022Applicant: MeMed Diagnostics Ltd.Inventors: Eran EDEN, Kfir OVED, Assaf COHEN-DOTAN, Roy NAVON, Olga BOICO, Meital PAZ
-
Publication number: 20220326238Abstract: A method of measuring risk assessment in a patient with appendicitis is disclosed. The method comprises: (a) measuring the TRAIL protein level in a blood sample of the patient; and (b) providing a risk assessment based on the TRAIL protein level.Type: ApplicationFiled: June 5, 2022Publication date: October 13, 2022Applicant: MeMed Diagnostics Ltd.Inventors: Kfir OVED, Eran EDEN, Assaf COHEN-DOTAN, Roy NAVON, Niv Steven MASTBOIM, Olga BOICO, Meital PAZ
-
Patent number: 11466331Abstract: Methods of determining infection type are disclosed. In one embodiment, the method comprises measuring the amount of a determinant which is set forth in Tables 1 or 2 in a sample derived from the subject, wherein said amount is indicative of the infection type.Type: GrantFiled: March 2, 2017Date of Patent: October 11, 2022Assignee: MeMed Diagnostics Ltd.Inventors: Kfir Oved, Eran Eden, Olga Boico, Gali Kronenfeld, Roy Navon, Assaf Cohen-Dotan, Einav Simon
-
Patent number: 11450406Abstract: A method of analyzing biological data containing expression values of a plurality of polypeptides in the blood of a subject. The method comprises: calculating a distance between a segment of a curved line and an axis defined by a direction, the distance being calculated at a point over the curved line defined by a coordinate along the direction. The method further comprises correlating the distance to the presence of, absence of, or likelihood that the subject has, a bacterial infection. The coordinate is defined by a combination of the expression values, wherein at least 90% of the segment is between a lower bound line and an upper bound line.Type: GrantFiled: August 20, 2020Date of Patent: September 20, 2022Assignee: MeMed Diagnostics Ltd.Inventors: Eran Eden, Kfir Oved, Roy Navon, Assaf Cohen-Dotan, Olga Boico
-
Publication number: 20220236269Abstract: Methods of determining infection type are disclosed. In one embodiment, the method comprises measuring the amount of TRAIL and/or IP10 no more than two days from symptom onset.Type: ApplicationFiled: April 11, 2022Publication date: July 28, 2022Applicant: MeMed Diagnostics Ltd.Inventors: Eran EDEN, Kfir OVED, Assaf COHEN-DOTAN, Roy NAVON, Olga BOICO, Meital PAZ
-
Patent number: 11385241Abstract: A method of determining a management course for treating a subject showing symptoms of a disease is disclosed. The method comprises measuring the TRAIL protein level in a blood sample of the subject, wherein when the TRAIL level is below a predetermined amount, the subject is treated as a high-risk patient.Type: GrantFiled: September 27, 2017Date of Patent: July 12, 2022Assignee: MeMed Diagnostics Ltd.Inventors: Eran Eden, Kfir Oved, Assaf Cohen-Dotan, Roy Navon, Olga Boico, Meital Paz
-
Patent number: 11353456Abstract: A method of measuring risk assessment in a patient with appendicitis is disclosed. The method comprises: (a) measuring the TRAIL protein level in a blood sample of the patient; (b) providing a risk assessment based on the TRAIL protein level.Type: GrantFiled: September 27, 2017Date of Patent: June 7, 2022Assignee: MeMed Diagnostics Ltd.Inventors: Kfir Oved, Eran Eden, Assaf Cohen-Dotan, Roy Navon, Niv Steven Mastboim, Olga Boico, Meital Paz
-
Patent number: 11340223Abstract: Methods of determining infection type are disclosed. In one embodiment, the method comprises measuring the amount of TRAIL and/or IP10 no more than two days from symptom onset.Type: GrantFiled: July 10, 2017Date of Patent: May 24, 2022Assignee: MeMed Diagnostics Ltd.Inventors: Eran Eden, Kfir Oved, Assaf Cohen-Dotan, Roy Navon, Olga Boico, Meital Paz
-
Publication number: 20220011320Abstract: Methods of diagnosing infections are disclosed. In one embodiment, the method comprises measuring the amount of each of the polypeptides TRAIL, CRP, IP10 and at least one additional polypeptide selected from the group consisting of IL-6 and PCT.Type: ApplicationFiled: July 12, 2021Publication date: January 13, 2022Applicant: MeMed Diagnostics Ltd.Inventors: Eran EDEN, Kfir OVED, Assaf COHEN-DOTAN, Roy NAVON, Olga BOICO, Gali KRONENFELD, Meital PAZ, Ellen BAMBERGER
-
Patent number: 11131671Abstract: Methods of diagnosing infections are disclosed. In one embodiment, the method comprises measuring the amount of each of the polypeptides TRAIL, CRP, IP10 and at least one additional polypeptide selected from the group consisting of IL-6 and PCT.Type: GrantFiled: January 3, 2019Date of Patent: September 28, 2021Assignee: MeMed Diagnostics Ltd.Inventors: Eran Eden, Kfir Oved, Assaf Cohen-Dotan, Roy Navon, Olga Boico, Gali Kronenfeld, Meital Paz, Ellen Bamberger
-
Patent number: 11081206Abstract: A method of analyzing biological data containing expression values of a plurality of polypeptides in the blood of a subject. The method comprises: calculating a distance between a segment of a curved line and an axis defined by a direction, the distance being calculated at a point over the curved line defined by a coordinate along the direction. The method further comprises correlating the distance to the presence of, absence of, or likelihood that the subject has, a bacterial infection. The coordinate is defined by a combination of the expression values, wherein at least 90% of the segment is between a lower bound line and an upper bound line.Type: GrantFiled: March 18, 2019Date of Patent: August 3, 2021Assignee: MeMed Diagnostics Ltd.Inventors: Eran Eden, Kfir Oved, Roy Navon, Assaf Cohen-Dotan, Olga Boico
-
Publication number: 20200393463Abstract: A method of determining an infection type in a subject is disclosed. The method comprises measuring the concentration of a first determinant selected from the group consisting of the determinants which are set forth in Table 1 and a second determinant selected from the group of the determinants which are set forth in Table 2 in a subject derived sample, wherein the concentration is indicative of the infection type.Type: ApplicationFiled: August 31, 2020Publication date: December 17, 2020Applicant: MeMed Diagnostics Ltd.Inventors: Kfir OVED, Eran EDEN, Gali KRONENFELD, Olga BOICO, Roy NAVON, Assaf COHEN-DOTAN
-
Publication number: 20200388347Abstract: A method of analyzing biological data containing expression values of a plurality of polypeptides in the blood of a subject. The method comprises: calculating a distance between a segment of a curved line and an axis defined by a direction, the distance being calculated at a point over the curved line defined by a coordinate along the direction. The method further comprises correlating the distance to the presence of, absence of, or likelihood that the subject has, a bacterial infection. The coordinate is defined by a combination of the expression values, wherein at least 90% of the segment is between a lower bound line and an upper bound line.Type: ApplicationFiled: August 20, 2020Publication date: December 10, 2020Applicant: MeMed Diagnostics Ltd.Inventors: Eran EDEN, Kfir OVED, Roy NAVON, Assaf COHEN-DOTAN, Olga BOICO
-
Publication number: 20200325219Abstract: An antibody comprising an antigen recognition domain that binds specifically the extracellular domain of TNF-related apoptosis-inducing ligand (TRAIL) between amino acids 95-155 and/or amino acids 190-210 is disclosed. Uses thereof are also disclosed.Type: ApplicationFiled: May 7, 2020Publication date: October 15, 2020Applicant: MeMed Diagnostics Ltd.Inventors: Olga BOICO, Salit TZABAN, Kfir OVED, Assaf COHEN-DOTAN, Eran EDEN